Table 2.
COVID (+) (n = 24) | COVID (-) (n = 138) | p-value | |
---|---|---|---|
Gender (n; %) | |||
Female | 20 (83%) | 119 (86%) | 0.707^ |
Male | 4 (17%) | 19 (14%) | |
Age (median; IQR) | 81 years (75-88) | 81 years (77-89) | 0.370* |
Charlson comorbidity index (Median; IQR) | 2 (0-3) | 1 (0-2) | 0.05* |
Comorbidities (n; %) | |||
Diabetes | 4 (17%) | 34 (25%) | 0.395^ |
Coexisting lung disease | 2 (8%) | 15 (11%) | 1^ |
Cardiopathy | 5 (21%) | 24 (17%) | 0.773^ |
Hypertension | 14 (58%) | 79 (57%) | 0.921^ |
Active smoking (n; %) | 4 (17%) | 17 (12%) | 0.520^ |
ASA score (median; IQR) | 2 (2-3) | 2 (2-2) | 0.035* |
Type of fracture (n, %) | |||
Femoral neck | 8 (33%) | 60 (43%) | 0.637^ |
Intertrochanteric | 15 (63%) | 74 (54%) | |
Subtrochanteric | 1 (4%) | 4 (3%) | |
Side (n, %) | |||
Left | 10 (42%) | 62 (45%) | 0.827^ |
Right | 14 (58%) | 76 (75%) | |
Time from admission to surgery (Days, median; IQR) | 5 days (3-8) | 3 days (1-6) | 0.017^ |
Treatment (n, %) | |||
Non-operative | 3 (13%) | 0 | 0.003^ |
Operative | 21 (87%) | 138 (100%) | 0.385^ |
Internal fixation | 15 (71%) | 82 (59%) | |
Hemiarthroplasty | 4 (19%) | 25 (18%) | |
Total hip arthroplasty | 2 (10%) | 31 (23%) | |
Type of hospital being treated at (n; %) | |||
Private | 2 (8%) | 50 (36%) | 0.007^ |
Public | 22 (92%) | 88 (64%) |
Abbreviations: ASA, American Society of Anesthesiologists; IQR, interquartile range.
* Mann Whitney Test.
^ Chi-square or Fisher’s test.